… DOX from tissues requires more time than its distribution [Citation… A recent experiment
has developed PEGylated platinum … strategies for modification of GO nanosheets is layer-by-layer …

… of co-delivery of Pt and DOX by PEGylated nano-graphene … We demonstrated that pGO
nanosheets had enhanced … system accumulation and improved tumor passive targeting effect. …

… of siRNA to liver tumor tissues by GO-PEG nanocarrier [86]. … They found that MnO 2 -FA-GO
nanosheets were significantly … to increase the accumulation of Ce6 in tumor cells and …

… in tumor tissue from the brain demonstrated that Tf–PEG–GO… a promising strategy through
co-delivery of drugs within the … on the surface of GO nanosheets in the presence of PEG. A …

… in vivo distribution with a higher accumulation in cancer cells and … Therefore, it is of
importance to study the safety of our fabricated … In summary, a new nanovehicle of PEG-PCL-SS-DOX …

… cancer cells [19]. Non-viral, synthetic carriers are commonly preferred to carry siRNA to avoid
serious concerns about the safety … in human tumors, causing alterations in distribution and …

… (SN38) to the PEGylated graphene oxide sheets by Van der … their co-delivery engenders
combined influence upon breast … (PEG-PCL-SS-DOX) was coupled to the GO nanosheets to …

… size (50–200 nm) have an enhanced permeability and retention (EPR) effect on tumor tissues,
which can infiltrate into and gather inside the tumor tissue for a better treatment effect. (32) …

… NIR region, graphene derivatives such as graphene oxide (GO) … the use of GO-PEG-polyethyleneimine
(GO–PEG–PEI), suggesting it … synergistic effect in co-delivery of CPT and DIM [92] …

… was much greater than that of graphene oxide [33]. Therefore, … the cytotoxicity of PEGylated
MoS 2 nanosheets as a drug … , mainly because the nanosheets accumulated in the tumor by …